Research location
Abington
Pennsylvania, United States
Advertisement
Research activity in Abington
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 186 trials and 192 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Abington
186 linked trials · page 1 of 4CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNCT07207811 · 2025-10-02 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseaseNCT06976216 · 2025-07-14 · 1 site observation
RECRUITING
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyNCT06979362 · 2025-06-27 · 1 site observation
RECRUITING
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerNCT06989112 · 2025-03-27 · 1 site observation
RECRUITING
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureNCT06526195 · 2024-12-13 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
ACP-204 in Adults With Alzheimer's Disease PsychosisNCT06159673 · 2023-11-14 · 1 site observation
RECRUITING
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureNCT05677100 · 2023-08-23 · 1 site observation
RECRUITING
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung CancerNCT05502523 · 2022-08-31 · 1 site observation
RECRUITING
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's DiseaseNCT06822517 · 2025-03-05 · 1 site observation
TERMINATED
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseNCT06602258 · 2024-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)NCT06357832 · 2024-04-29 · 1 site observation
COMPLETED
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension StudyNCT06194799 · 2024-04-23 · 1 site observation
ENROLLING_BY_INVITATION
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD SubjectsNCT06304883 · 2024-04-02 · 1 site observation
TERMINATED
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)NCT06335173 · 2024-02-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisNCT06141473 · 2023-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)NCT06122779 · 2023-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseNCT05531656 · 2023-06-28 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)NCT05592275 · 2023-02-03 · 1 site observation
TERMINATED
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)NCT05619692 · 2022-11-29 · 1 site observation
COMPLETED
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989 · 2022-08-03 · 1 site observation
COMPLETED
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.NCT05408039 · 2022-07-14 · 1 site observation
COMPLETED
Ultrafiltration Versus IV Diuretics in Worsening Heart FailureNCT05318105 · 2022-06-28 · 1 site observation
TERMINATED
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseNCT05310071 · 2022-06-02 · 1 site observation
TERMINATED
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisNCT05269004 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the USNCT05097131 · 2021-11-18 · 1 site observation
TERMINATED
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)NCT05108922 · 2021-11-16 · 1 site observation
COMPLETED
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early ADNCT03919162 · 2021-11-15 · 1 site observation
TERMINATED
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based TherapyNCT05116813 · 2021-10-25 · 1 site observation
TERMINATED
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseNCT05063539 · 2021-09-16 · 1 site observation
COMPLETED
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based TherapyNCT04857359 · 2021-08-06 · 1 site observation
TERMINATED
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADNCT04931459 · 2021-06-21 · 1 site observation
COMPLETED
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNCT04916470 · 2021-06-15 · 1 site observation
COMPLETED
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsNCT04770220 · 2021-05-19 · 1 site observation
COMPLETED
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityNCT04788511 · 2021-03-16 · 1 site observation
COMPLETED
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's DiseaseNCT04639050 · 2021-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)NCT04374253 · 2021-01-26 · 1 site observation
TERMINATED
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's DiseaseNCT04592874 · 2021-01-22 · 1 site observation
COMPLETED
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)NCT04640077 · 2020-11-23 · 1 site observation
COMPLETED
Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart FailureNCT03458325 · 2020-11-12 · 1 site observation
COMPLETED
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseNCT04520412 · 2020-10-27 · 1 site observation
SUSPENDED
Implementation of Function Focused Care in Acute CareNCT04235374 · 2020-10-19 · 1 site observation
COMPLETED
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidNCT04468659 · 2020-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)NCT04437511 · 2020-06-19 · 1 site observation
ACTIVE_NOT_RECRUITING
PROACTIVE-HF IDE Trial Heart Failure NYHA Class IIINCT04089059 · 2020-01-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)NCT03988634 · 2019-06-29 · 1 site observation
COMPLETED
TRC-PAD Program: In-Clinic Trial-Ready CohortNCT04004767 · 2019-06-04 · 1 site observation
COMPLETED
DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection FractionNCT03877237 · 2019-04-09 · 1 site observation
COMPLETED
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection FractionNCT03877224 · 2019-04-04 · 1 site observation
COMPLETED
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS PatientsNCT03623243 · 2019-02-14 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.